The gut microbiota and the bile acid pool play pivotal roles in maintaining intestinal homeostasis. Bile acids are produced in the liver from cholesterol and metabolized in the intestine by the gut microbiota. Gut dysbiosis has been reported to be associated with colorectal cancer. However, the interplay between bile acid metabolism and the gut microbiota during intestinal carcinogenesis remains unclear. In the present study, we investigated the potential roles of bile acids and the gut microbiota in the cholic acid (CA; a primary bile acid)-induced intestinal adenoma-adenocarcinoma sequence. Apc min/+ mice, which spontaneously develop intestinal adenomas, were fed a diet supplemented with 0.4%
| INTRODUCTION
Colorectal cancer (CRC) is one of the most frequently diagnosed human cancers and a leading cause of cancer-related death worldwide. 1 According to epidemiological and experimental studies, a highfat diet (HFD) may be involved in the development of CRC. 2 More importantly, HFD-related CRC has been reported to be associated with excess bile acid, and a substantial body of evidence suggests that bile acids play a vital role in CRC progression. [3] [4] [5] [6] [7] [8] The gut microbiota plays a decisive role in the internal environment homeostasis by facilitating the harvesting of nutrients from ingested food and producing numerous metabolites for the human body. Bile acids are produced in the liver from cholesterol and metabolized in the intestine by the gut microbiota. In recent years, interest in HFD-associated intestinal dysbiosis has increased; an HFD enhances bile secretion to facilitate lipid metabolism. Primary bile acids undergo modifications to secondary bile acids by 7α-dehydroxylation reactions catalyzed by some species of Clostridium. 9 The most typical secondary bile acid is deoxycholic acid (DCA), which is produced from cholic acid (CA).
Adenomatous polyposis coli (Apc) gene mutations occur in 95% of human sporadic CRCs 10 and represent one of the earliest events in the adenoma-adenocarcinoma sequence. 11 Multiple intestinal neoplasia (Apc min/+ ) mice spontaneously develop multiple tumors in the intestine and are an established model for studying intestinal carcinogenesis. In our previous work, we aimed to determine the effects of DCA on intestinal carcinogenesis in Apc min/+ mice and found that DCA accelerates the intestinal adenoma-adenocarcinoma sequence. 12 Next, we investigated the effect of DCA on the induction of intestinal dysbiosis and its roles in intestinal carcinogenesis and demonstrated that DCA-induced changes to the microbial community promoted intestinal carcinogenesis. 13 The secondary bile acid DCA arises from CA, which is present in excess after HFD consumption. The intestinal microbiota participates in the biotransformation of CA to DCA. Thus, in this study, we assume that dysbiosis of the microbiota and associated alterations of metabolism might also influence intestinal carcinogenesis. In this paper, Apc min/+ mice were fed a basal, CAsupplemented or CA-antibiotic diet. We found that CA enhanced the intestinal adenoma-adenocarcinoma sequence in Apc min/+ mice, which was accompanied by alterations in the gut microbiota and metabolites.
An antibiotic cocktail globally prevented the carcinogenic effect of CA in vivo. Moreover, CA-induced intestinal tumor development was mediated by the interleukin 6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling pathway. These findings highlight the crosstalk between bile acids and the gut microbiota, thereby providing novel insight into therapeutic targets for CRC prevention. The mice were divided into three groups: a control diet (Table S1) (control group, n = 10), a diet supplemented with 0.4% CA (CA group, n = 10), and a 0.4% CA diet with a daily dose of an antibiotic cocktail administered by gavage (CA-Abx group, n = 10). We chose 0.4% w/w CA according to previous studies and our experiments. [13] [14] [15] In addition, 0.5% (w/w) chenodeoxycholate (another primary bile acid)
| MATERIALS AND METHODS

| Mice and treatment
was administered as a 10-week dietary treatment in Apc min/+ mice to increase duodenal tumors. 15 In our previous work, Apc min/+ mice were also fed 0.5% CA in the diet; however, when the mice were fed this concentration of CA, feed intake significantly decreased. Considering the longer experimental period, 0.4% w/w CA was used in this study.
The antibiotic cocktail was a mixture of 500 mg of ampicillin, 250 mg of vancomycin, 500 mg of neomycin, and 250 mg of metronidazole (Sigma-Aldrich, St. Louis, MO) based on previous studies. [16] [17] [18] [19] [20] After 12 weeks, the mice were killed, and the cecal contents were immediately collected for further analysis. Small intestine and colon tissues were collected for histologic analysis. Fecal samples were collected for 1 day at the end of the experimental period for gut microbiota and bile acid analysis.
| Intestinal tumor burden and tissue collection
The small intestine was divided into three equal sections (proximal, middle, and distal segments). Intestinal tumors were categorized as small (<1 mm), medium (1-2 mm), or large (>2 mm). Swiss rolled distal small intestine and colon tissues were fixed in 10% buffered formalin. 12, 21 The tissue sections were used for hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining.
| Histopathologic and IHC analysis
Formalin-fixed sections were dehydrated, equilibrated, and embedded in paraffin. Sections of the distal small intestine and colon were stained with H&E and observed under a light microscope by a blinded pathologist (Dr. YJZ). The degree of tumor dysplasia was assessed. Low-grade intraepithelial neoplasia (LGIN) was defined as low-and moderate-grade dysplasia and high-grade intraepithelial neoplasia (HGIN) included highgrade dysplasia, carcinoma in situ and intramucosal carcinoma.
The expression of β-catenin (Cell Signaling Technology, Boston, MA) and mucin 2 (MUC2) in the colon (Santa Cruz Biotechnology, Inc., Santa, Cruz, CA) and Ki-67, defensin, STAT3, and p-STAT3 (Tyr705) (Abcam, Cambridge, MA) in the small intestine was detected (Table S2) 
| Real-time PCR analysis
Total RNA was isolated using the RNeasy mini kit (Qiagen, Carlsbad, CA) and reverse-transcribed with a TIANScript RT Kit (Tiangen, Inc., Beijing, China). Quantitative PCR was performed using the Power Table S3 . GAPDH was used as the control, and the −ΔΔ 2 Ct method was used to evaluate the relative abundance of target genes.
| Western blot analysis
Cell protein extracts were prepared following standard procedures in radioimmunoprecipitation assay buffer in the presence of protease Table S2 ) overnight at 4°C
. Next, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies for 1 hour at room temperature. The proteins were quantified by densitometry using the ImageJ software.
| Intestinal barrier integrity
Intestinal barrier integrity was assessed by permeability to fluorescein isothiocyanate-dextran (FITC-D) before the mice were killed.
FITC-D was dissolved in water (4000 MW) and administered by gavage (600 mg/kg body weight). Whole blood was sampled by eyeball extirpation 4 hours after the procedure, and the mice were killed. The fluorescence intensity in the plasma was analyzed using a plate reader. This procedure was performed in separate groups of mice, and the concentration of FITC-dextran in plasma was determined by comparison to a FITC-dextran standard curve. were monitored on 1% agarose gels. DNA was diluted to 1 ng/μL using sterile water. The V3-V4 hypervariable regions of the 16S ribosomal RNA genes were amplified using specific barcoded
primers. An equal volume of 1× loading buffer (containing SYBR green) was used with the PCR products, and electrophoresis was performed on 2% agarose gel for the detection of the PCR products.
Equivalent amounts of the PCR products were mixed based on density. Then, the PCR product mixture was purified using the GeneJET Gel Extraction Kit (Thermo Fisher Scientific, Waltham, MA).
Sequencing libraries were generated using an Illumina HiSeq DNA PCR-Free Library Preparation Kit (Illumina, Santiago, CA). Raw sequence data from the Illumina platform were splice-controlled and quality-controlled to obtain clean tags. After chimera filtration, the effective data were available for subsequent analysis.
Sequences were analyzed using the QIIME software package (Quantitative Insights Into Microbial Ecology). 23 Effective tags were mapped into operational taxonomic units and selected based on ≥97%
similarity. The taxonomic analysis was based on the OTU sequences using the QIIME platform. 24 Community diversity was estimated using the Shannon and Simpson index. Principal component analysis (PCA) and principal coordinate analysis were performed on the matrix of distances between CA-treated and untreated groups. (TRC, Toronto, Canada) were added to fecal samples as reference standards, and an external standard method was used for preliminary measurement. The concentration of bile acids in feces was measured using liquid chromatography-mass spectrometry, as previously described. 25 Briefly, freeze-dried feces were thoroughly ground.
The fecal samples were suspended in 5 mL of chromatographic ethanol and extracted by vortexing and sonication at 30°C for 60 minutes. The pooled extract was then centrifuged twice (10 minutes, 10 000 rpm, 4°C). The supernatant (4 mL) was concentrated to dry under nitrogen. Chromatographic methanol was used to redissolve the samples, and the extracts were passed through a 0.22-μm filter.
The filtrate was stored at 4°C and analyzed with an Agilent 1260
Series liquid chromatography combined with a 6120B mass spectrometer. The concentration of individual bile acids in each group was calculated based on peak areas.
| Analysis of short-chain fatty acids in the cecal contents
The concentrations of short-chain fatty acids (SCFAs; acetate, propionate and butyrate) in the cecal contents were measured using gas chromatography. Acetic acid, propionic acid, and butyric acid Feces from the control group, CA group, and CA-Abx group were suspended in sterile phosphate-buffered saline (100 mg/mL), homogenized, and centrifuged at 1000 rpm for 5 seconds. The fecal contents were filtered using a 40-μm cell strainer (BD Falcon) to remove aggregates and collect fecal bacteria content, which was used to stimulate the IMCE cell line at a 1:200 dilution based on a previous study. 20 Figure 1D ). Tumor size in the small intestine and the colon also increased ( Figure 1E and 1F) .
Moreover, CA supplementation of the diet also led to intestinal carcinogenesis. In the distal small intestine, HGIN, including highgrade dysplasia (50%, 5/10) and intramucosal carcinomas (30%, 3/10), was detected in CA group mice, whereas age-matched Apc min/+ mice on a normal diet developed only adenoma with or without LGIN ( Figure 1G ). Ki-67 and β-catenin expression levels were also increased in CA-fed mice ( Figure 1H ). These findings suggest that CA enhanced the multiplicity of intestinal tumors and accelerated the intestinal adenoma-adenocarcinoma sequence in Apc min/+ mice. Adenomas were histologically identified in Apc min/+ mice fed a control diet, and intramucosal carcinoma was confirmed in the distal small intestines in CA-fed Apc min/+ mice (hematoxylin and eosin). H, Immunohistochemistry results indicate that cell proliferation (Ki-67) and nuclear β-catenin accumulation in the small intestine were significantly increased in CA-treated Apc min/+ mice compared with those in the control group. Scale bar = 50 μm. Ten mice for each group. *P < 0.05, **P < 0.01, and ***P < 0.001. Apc, adenomatous polyposis coli; CA, cholic acid [Color figure can be viewed at wileyonlinelibrary.com] WANG ET AL.
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the relative abundance of Bacteroidetes and Verrucomicrobia increased to 57.6% and 22.0%, respectively, in the CA group, with a significant decrease in Firmicutes. The fecal microbial community was strikingly altered by CA administration ( Figure 2C ; CA group: n = 5; control group: n = 4). The reduction in Firmicutes partly resulted from an increase in the Clostridia class ( Figure 2C ). To investigate the differences between the groups, the taxa with significant differences between the two groups at the genus level are shown in Figure 2D .
Normal colonic bacteria ferment dietary fiber and generate SCFAs.
The most abundant SCFAs included acetate, propionate, and butyrate.
Previous studies have suggested that the increased risk of colon cancer might be partly explained by the reduced production of antineoplastic SCFAs. 28 The bacteria that produce the most SCFAs are
Firmicutes in Clostridium clusters IV and XIVa. 29 SCFAs were detected in the cecal contents in this study; as shown in Figure 3A , the fecal concentration of SCFAs was significantly decreased in CA-fed mice.
F I G U R E 2
The fecal microbiota composition was significantly altered by CA administration. A, Principal component analysis (PCA) of the fecal microbiota in CA-fed mice (n = 5) and untreated mice (n = 4). B, β diversities of the CA group (n = 5) and the control group (n = 4). C, Population analysis for each diet group included the phyla, classes, and major genera identified. The mean percentage (%) of the total population is presented. D, The taxa with significant differences between the two groups at the genus level are shown. CA, cholic acid; CON, control group; n, the number of the mice [Color figure can be viewed at wileyonlinelibrary.com]
These findings indicated that CA diet-induced dysbiosis might further reduce SCFA production and promote intestinal carcinogenesis.
| CA-induced dysbiosis increased DCA production
Bile acid composition in the intestine is determined by a combination of bile acid biosynthesis in the liver and bioconversion by intestinal bacteria. 9 We detected fecal concentrations of bile acids after CA treatment. As shown in Figure 3B , CA administration dramatically increased the fecal concentrations of both administered CA and bactericidal DCA, whereas the levels of muricholic acids (α-MCA and β-MCA, the main primary bile acids in mice) were generally unaffected. This finding clearly indicated that CA in the diet was primarily transformed into DCA by bacterial 7α-dehydroxylation in mice, which is similar to that observed in the human colon. 9 Bile acids were previously reported to exhibit antimicrobial effects by disrupting membrane integrity. 30 Thus, these results suggest that increased bile acid concentrations might also apply a strong selective pressure that subsequently alters the composition of the intestinal microbiota.
| CA-induced dysbiosis contributed to impaired gut barrier function and low-grade intestinal inflammation
The intestinal permeability of CA-treated mice significantly increased (P < 0.01; n = 10; Figure 4A ). IL-6, IL-1β, and TNF-α mRNA levels were upregulated by CA treatment ( Figure 4B ). Emerging evidence indicates that intestinal dysbiosis influences mucus barrier biology. 32 The relative abundance of Akkermansia and Bacteroides increased by approximately 7% and 5%, respectively, in the CA group compared with that in the control group ( Figure 2D ). These bacteria are associated with increased intestinal inflammation and impaired gut barrier function. 33, 34 In particular, our findings demonstrated decreased ZO-1, claudin 3, claudin 7, and MUC2 mRNA expression ( Figure 4C ). PAS and MUC2 staining revealed that the CA diet decreased the number and secretory function of goblet cells, which play a vital role in maintaining the thick mucus layer ( Figure 4D ). Cryptidin and defensin mRNA expression was reduced in CA-fed mice, and lysozyme staining also suggested impaired Paneth cell function ( Figure 4C and 4D ).
| An antibiotic cocktail prevented CA-induced intestinal carcinogenesis
To further determine the role of the gut microbiota in CA-induced intestinal carcinogenesis, CA-fed Apc min/+ mice were simultaneously administered an antibiotic cocktail by gavage for 12 weeks to deplete the gut microbiota (n = 10). The number of tumors in all sections of the small intestine and colon decreased ( Figure 5A and 5B). In addition, the numbers of tumors of all sizes in the small intestine (<1, 1-2, and >2 mm) in CA-Abx-treated mice were dramatically decreased compared with those in the CA-treated group ( Figure 5C ). In the colon, the number of larger tumors (1-2 and >2 mm) also decreased significantly ( Figure 5D ). No HGIN was found in the distal small intestine or colon after antibiotic cocktail treatment ( Figure 5E ). Antibiotic administration in the CA group also led to a significant reduction in tumor multiplicity, suggesting that the gut microbiota plays a crucial role in CA-induced intestinal carcinogenesis.
| CA-induced intestinal dysbiosis activated the IL-6/STAT3 pathway
Recent evidence suggests a crucial role for STAT3 in the induction and maintenance of a pro-carcinogenic inflammatory microenvironment both during the initiation of malignant transformation and during cancer progression. 35, 36 Notably, IL-6 is one of the most important STAT3 activators. [36] [37] [38] As shown in Figure 6 , IL-6 mRNA F I G U R E 3 Effects of cholic acid (CA) treatment on short-chain fatty acid production and bile acid metabolism in Apc min/+ mice. A, Types of short-chain fatty acids, including acetate, propionate, and butyrate, detected in the cecal contents. B, Types of bile acids detected in the feces, including CA, chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), α-muricholic acid (α-MCA), and β-muricholic acid (β-MCA). *P < 0.05, **P < 0.01, and ***P < 0.001. Apc, adenomatous polyposis coli [Color figure can be viewed at wileyonlinelibrary.com] expression and p-STAT3 levels in intestinal tissues were increased after CA exposure, whereas no significant difference in total STAT3 expression was observed (n = 10) ( Figure 6A and 6B). The increased IL-6 and p-STAT3 expressions were significantly decreased by CAAbx treatment ( Figure 6A ). immune activity. 45 Gut microbiota alterations further influence host metabolism, including SCFA production. Our previous work demonstrated that DCA-induced dysbiosis could be transferred to mice and lead to intestinal carcinogenesis. 13 Thus, we hypothesize that the complex interactions between bile acids and the intestinal microbiota significantly influence cancer development. This study demonstrates that the progression of intestinal adenoma in the Apc min/+ mouse model was promoted by the interplay between bile acids and the gut microbiota. The increase in some mucin-degrading bacteria, such as Akkermansia, might facilitate this progression. Moreover, decreased protective SCFAs, increased DCA production, and STAT3 signaling pathway activation are also involved in malignant tumor progression.
SCFAs are generated by SCFA-producing bacteria as fermentation products from dietary fibers. 46 we focus on the mucus system, mucin-producing cells in the colon, The 7α-dehydroxylation reaction, which is one of the most important steps in the production of secondary bile acids, eliminates the functional hydroxyl group and increases the hydrophobicity of the molecule. Among these bile acids, one of the most toxic secondary bile acids is DCA, which is produced from CA. In our data, fecal concentrations of DCA were dramatically increased after the CA administration. High DCA concentrations (>1 mmol/L) inhibit the growth of many intestinal bacteria, including Clostridium perfringens, Bacteroides fragilis, lactobacilli, and bifidobacteria in vitro. 32 Thus, it is reasonable to consider that the interaction between bile acids and the gut microbiota controls the progression of intestinal adenoma.
A previous study suggested that feeding 0.4% CA could induce liver damage and increase serum glutamic-pyruvic transaminase and glutamic-oxaloacetic transaminase. 58 We also found that inflammatory cell infiltration in the liver was increased in the CA group in our study ( Figure S1 ). Liver disease has been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. The liver can not clear the toxic metabolites (such as ammonia and LPS) from intestinal bacteria when it is injured by CA. Excessive LPS may further alter the composition of the gut microbiota.
Therefore, the altered gut microbiota in the present study might also be associated with liver damage. This represents that liver damage is a confounding factor in the study of gut microbiota.
The importance of inflammation and immunobiology in malignant progression has become a recent focus of attention. Some other limitations of this study should be noted. First, the study lacked a control group that received sham oral gavage without antibiotics and a control group that received oral gavage with antibiotics, which represents a confounding effect in our study. We can not contrast the intestinal microbiome of CA+antibiotics mice to control+antibiotic mice. The experimental design will be planned more carefully in the future. Second, we acknowledged the statistical limitations of the study due to the small sample size. Third, the method used to quantify fecal bile acids is not standard. Typically, deuterium-labeled standards should be added as internal controls.
The lack of deuterium-labeled standards to determine extraction efficiency makes it difficult to compare samples accurately.
Overall, the interplay between CA and the gut microbiota plays a crucial role in the progression of intestinal adenoma. These findings suggested that the complex interaction between bile acids and the gut microbiota serves as a promising avenue for CRC treatment.
